Fortitude Family Office’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.86K Hold
97
﹤0.01% 1312
2025
Q4
$2.13K Buy
+97
New +$1.75K ﹤0.01% 1150
2025
Q3
Sell
-82
Closed -$1.53K 2141
2025
Q2
$1.53K Buy
+82
New +$1.62K ﹤0.01% 1323
2025
Q1
Sell
-21
Closed -$756 1273
2024
Q4
$756 Hold
21
﹤0.01% 1174
2024
Q3
$891 Buy
+21
New +$890 ﹤0.01% 1110

Other funds holding TNDM

Fortitude Family Office's TNDM Position: Q1 2026 in Review

Fortitude Family Office held its Tandem Diabetes Care (TNDM) position steady in Q1 2026 at 97 shares worth $1.86K. The position accounts for ﹤0.01% of the portfolio, ranked #1312.

Fortitude Family Office first reported a position in TNDM in Q3 2024 and has held it in 5 quarters since. The position peaked at $2.13K in Q4 2025. 272 funds tracked by Wall St. Rank hold TNDM as of Q1 2026.

  • Fortitude Family Office held 97 shares of Tandem Diabetes Care worth $1.86K as of Q1 2026.
  • Fortitude Family Office left its Tandem Diabetes Care share count unchanged in Q1 2026.
  • Tandem Diabetes Care made up ﹤0.01% of Fortitude Family Office's portfolio in Q1 2026, its #1312 holding.
  • Fortitude Family Office first reported a position in Tandem Diabetes Care in Q3 2024 and has held it in 5 quarters since.
  • Fortitude Family Office's Tandem Diabetes Care position peaked at $2.13K in Q4 2025.
  • 272 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2026.

Based on Fortitude Family Office's 13F filing for Q1 2026, filed 16 Apr 2026.